中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2014年
17期
1318-1321
,共4页
郭发金%任俊红%王思宇%戴维德%马娜
郭髮金%任俊紅%王思宇%戴維德%馬娜
곽발금%임준홍%왕사우%대유덕%마나
超声检查%磁共振成像%直肠肿瘤
超聲檢查%磁共振成像%直腸腫瘤
초성검사%자공진성상%직장종류
Ultrasonography%Magnetic resonance imaging%Rectal neoplasms
目的 比较分析经直肠双平面彩超(ERUS)与磁共振成像技术(MRI)在直肠癌术前分期中的应用价值.方法 收集2010年9月至2012年12月北京医院直肠癌住院患者44例病例资料.患者分别行直肠双平面彩超检查与磁共振显像,所有病例均经手术、病理确诊.结果 本资料中,腺癌40例,类癌1例,间质瘤(低度恶性)1例,腺瘤癌变2例.ERUS判断直肠癌浸润肠壁深度uT1、uT2、uT3、uT4的诊断符合率分别为95.5%、90.9%、93.2%、97.7%,总的诊断符合率为88.6%(39/44),灵敏性分别为83.3%、72.7%、72.2%、77.8%,特异性分别为97.3%、92.9%、96.2%、97.6%;MRI判断直肠癌浸润肠壁深度T1、T2、T3、T4的诊断符合率分别为93.2%、90.9%、93.2%、100.0%,总的诊断符合率为86.4% (38/44),灵敏性分别为71.4%、93.8%、94.4%、100.0%,特异性分别为97.3%、89.3%、92.3%、100.0%.ERUS对直肠癌术前分期与MRI比较差异无统计学意义.ERUS对肠周淋巴结转移判断的灵敏性为68.4% (13/19)、特异性为80.0%(20/25)、诊断符合率为75.0%(33/44);MRI对肠周淋巴结转移判断的灵敏性为94.7% (18/19)、特异性为92.0% (23/25)、诊断符合率为93.2% (41/44).结论 经直肠双平面彩超与磁共振同样能对直肠癌的术前准确分期,前者对T1期诊断准确率和敏感性较高,后者对肠周淋巴结转移判断更有优势.
目的 比較分析經直腸雙平麵綵超(ERUS)與磁共振成像技術(MRI)在直腸癌術前分期中的應用價值.方法 收集2010年9月至2012年12月北京醫院直腸癌住院患者44例病例資料.患者分彆行直腸雙平麵綵超檢查與磁共振顯像,所有病例均經手術、病理確診.結果 本資料中,腺癌40例,類癌1例,間質瘤(低度噁性)1例,腺瘤癌變2例.ERUS判斷直腸癌浸潤腸壁深度uT1、uT2、uT3、uT4的診斷符閤率分彆為95.5%、90.9%、93.2%、97.7%,總的診斷符閤率為88.6%(39/44),靈敏性分彆為83.3%、72.7%、72.2%、77.8%,特異性分彆為97.3%、92.9%、96.2%、97.6%;MRI判斷直腸癌浸潤腸壁深度T1、T2、T3、T4的診斷符閤率分彆為93.2%、90.9%、93.2%、100.0%,總的診斷符閤率為86.4% (38/44),靈敏性分彆為71.4%、93.8%、94.4%、100.0%,特異性分彆為97.3%、89.3%、92.3%、100.0%.ERUS對直腸癌術前分期與MRI比較差異無統計學意義.ERUS對腸週淋巴結轉移判斷的靈敏性為68.4% (13/19)、特異性為80.0%(20/25)、診斷符閤率為75.0%(33/44);MRI對腸週淋巴結轉移判斷的靈敏性為94.7% (18/19)、特異性為92.0% (23/25)、診斷符閤率為93.2% (41/44).結論 經直腸雙平麵綵超與磁共振同樣能對直腸癌的術前準確分期,前者對T1期診斷準確率和敏感性較高,後者對腸週淋巴結轉移判斷更有優勢.
목적 비교분석경직장쌍평면채초(ERUS)여자공진성상기술(MRI)재직장암술전분기중적응용개치.방법 수집2010년9월지2012년12월북경의원직장암주원환자44례병례자료.환자분별행직장쌍평면채초검사여자공진현상,소유병례균경수술、병리학진.결과 본자료중,선암40례,유암1례,간질류(저도악성)1례,선류암변2례.ERUS판단직장암침윤장벽심도uT1、uT2、uT3、uT4적진단부합솔분별위95.5%、90.9%、93.2%、97.7%,총적진단부합솔위88.6%(39/44),령민성분별위83.3%、72.7%、72.2%、77.8%,특이성분별위97.3%、92.9%、96.2%、97.6%;MRI판단직장암침윤장벽심도T1、T2、T3、T4적진단부합솔분별위93.2%、90.9%、93.2%、100.0%,총적진단부합솔위86.4% (38/44),령민성분별위71.4%、93.8%、94.4%、100.0%,특이성분별위97.3%、89.3%、92.3%、100.0%.ERUS대직장암술전분기여MRI비교차이무통계학의의.ERUS대장주림파결전이판단적령민성위68.4% (13/19)、특이성위80.0%(20/25)、진단부합솔위75.0%(33/44);MRI대장주림파결전이판단적령민성위94.7% (18/19)、특이성위92.0% (23/25)、진단부합솔위93.2% (41/44).결론 경직장쌍평면채초여자공진동양능대직장암적술전준학분기,전자대T1기진단준학솔화민감성교고,후자대장주림파결전이판단경유우세.
Objective To evaluate the diagnostic value of endorectal ultrasonography (ERUS) and magnetic resonance imaging (MRI) in preoperative staging of rectal carcinoma.Methods A total of 44 patients with biopsy proven rectal tumor underwent preoperative ERUS and MRI examinations.All patients were evaluated to determine the diagnostic accuracy of depth of transmural tumor invasion and lymph node metastases.Imaging results were compared with histopathological findings.Results The accuracy of T staging (uT1,uT2,uT3,uT4) for ERUS was 95.5%,90.9%,93.2% and 97.7% and the overall accuracy 88.6% (39/44).The sensitivity was 83.3%,72.7%,72.2%,77.8% and the specificity 97.3%,92.9%,96.2% and 97.6%.The accuracy ofT staging (T1,T2,T3,T4) for MRI was 93.2%,90.9%,93.2%,100.0% and the overall accuracy 86.4% (38/44).The sensitivity was 71.4%,93.8%,94.4% and 100.0% and the specificity 97.3%,89.3%,92.3% and 100.0%.Detection of lymph node metastases:the accuracy of ERUS was 75.0% (33/44),MRI 93.2% (41/44).The sensitivity and specificity was found to be 68.4% (13/19) and 80.0% (20/25) on ERUS,94.7% (18/19) and 92.0% (23/25) on MRI respectively.Conclusion ERUS and MRI may be used for accurate preoperative staging of rectal cancer.ERUS has higher accuracy and sensitivity for T1 stage while MRI is preferred for lymph node metastasis.